Hematology Analyzer and ReagentHematology analyzers are indispensable instruments in any clinical laboratory setting. These highly specialized tools count the number of white blood cells, red blood cells, and platelets to help physicians diagnose diseases such as infections, anemia, viruses, diabetes, genetic problems, and cancer. Fully automated and semi-automated hematology analyzers are available. Modern analyzers and quality hematology reagents enable processing of hundreds of samples an hour and deliver fast, accurate results, which are crucial for timely therapeutic interventions.

Clinical testing laboratories, hospitals, and research institutions are the end-users of hematology analyzers and reagents. According to a recent report from Persistence Market Research, the main factors driving the growth of the global hematology analyzer and reagent market are:

  • Increasing adoption of automated hematology instruments
  • Technological advancements
  • Integration of basic flow-cytometry techniques in modern hematology systems
  • Rising demand for high-throughput instruments
  • Development of high-sensitivity point-of-care (POC) hematology testing

However, there are various factors at play which restrain market growth such as the high cost of hematology analyzers, intense competition among existing players and time-consuming regulatory policies. Moreover, while the use of microfluidics technology in hematology analyzers and introduction of digital imaging system could open up opportunities for new players, safety and quality of hematology analyzers could pose challenges for market growth.

Geographically, North America dominates the market, followed by Europe. Asia is expected to be the fastest growing market in the next five years due to the developing healthcare infrastructure, rising awareness about better healthcare, a large patient population base and increasing funding towards the development of hematology products.

The report lists the leading manufacturers of hematology analyzers as Sysmex Corporation, Abbott Laboratories, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Mindray Medical International Limited, Siemens Healthcare, HORIBA, Ltd. and NIHON KOHDEN CORPORATION.